Jonathan Aschoff
Stock Analyst at Roth MKM
(0.66)
# 3,374
Out of 4,572 analysts
45
Total ratings
22.5%
Success rate
-27.21%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRTX BioRestorative Therapies | Maintains: Buy | $15 → $18 | $1.80 | +900.00% | 4 | Aug 14, 2024 | |
| NUWE Nuwellis | Reiterates: Buy | $17 | $1.38 | +1,131.88% | 2 | Aug 13, 2024 | |
| OTRK Ontrak | Maintains: Buy | $4 → $3 | $0.22 | +1,264.88% | 2 | Aug 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $20 | $2.71 | +638.01% | 1 | Jul 16, 2024 | |
| CYCC Cyclacel Pharmaceuticals | Maintains: Buy | $21 → $11 | $1.03 | +967.96% | 2 | May 3, 2024 | |
| MBRX Moleculin Biotech | Maintains: Buy | $40 | $2.41 | +1,559.75% | 2 | Apr 12, 2024 | |
| CLRB Cellectar Biosciences | Maintains: Buy | $20 → $28 | $2.08 | +1,246.15% | 4 | Mar 28, 2024 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $56 → $44 | $2.19 | +1,909.13% | 1 | Mar 28, 2024 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $12 → $40 | $1.00 | +3,900.80% | 2 | Mar 27, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $25 → $36 | $6.36 | +466.04% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $24 | $0.81 | +2,862.60% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.78 | +693.65% | 3 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $7.78 | +221.34% | 1 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $5.59 | +3,477.82% | 1 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.85 | +656.76% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $450 | $0.90 | +49,950.05% | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $8 | $1.17 | +583.76% | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $3.39 | +2,846.38% | 1 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $1.25 | +31,900.00% | 1 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $600 → $1,920 | $0.19 | +1,031,603.39% | 2 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2,816 → $2,200 | $0.33 | +666,566.67% | 2 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $6.30 | +503.17% | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $480 | $1.33 | +35,990.23% | 1 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $96 | $6.82 | +1,307.62% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $5.39 | - | 1 | Dec 19, 2019 |
BioRestorative Therapies
Aug 14, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $1.80
Upside: +900.00%
Nuwellis
Aug 13, 2024
Reiterates: Buy
Price Target: $17
Current: $1.38
Upside: +1,131.88%
Ontrak
Aug 9, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.22
Upside: +1,264.88%
GeoVax Labs
Jul 16, 2024
Initiates: Buy
Price Target: $20
Current: $2.71
Upside: +638.01%
Cyclacel Pharmaceuticals
May 3, 2024
Maintains: Buy
Price Target: $21 → $11
Current: $1.03
Upside: +967.96%
Moleculin Biotech
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $2.41
Upside: +1,559.75%
Cellectar Biosciences
Mar 28, 2024
Maintains: Buy
Price Target: $20 → $28
Current: $2.08
Upside: +1,246.15%
TFF Pharmaceuticals
Mar 28, 2024
Maintains: Buy
Price Target: $56 → $44
Current: $2.19
Upside: +1,909.13%
Bio-Path Holdings
Mar 27, 2024
Maintains: Buy
Price Target: $12 → $40
Current: $1.00
Upside: +3,900.80%
Mind Medicine (MindMed)
Mar 7, 2024
Maintains: Buy
Price Target: $25 → $36
Current: $6.36
Upside: +466.04%
Mar 5, 2024
Maintains: Buy
Price Target: $5 → $24
Current: $0.81
Upside: +2,862.60%
Feb 20, 2024
Reiterates: Buy
Price Target: $30
Current: $3.78
Upside: +693.65%
Oct 6, 2023
Reiterates: Buy
Price Target: $25
Current: $7.78
Upside: +221.34%
Aug 29, 2023
Reiterates: Buy
Price Target: $200
Current: $5.59
Upside: +3,477.82%
Aug 14, 2023
Reiterates: Buy
Price Target: $14
Current: $1.85
Upside: +656.76%
Feb 14, 2023
Maintains: Buy
Price Target: $150 → $450
Current: $0.90
Upside: +49,950.05%
Jun 15, 2022
Reinstates: Buy
Price Target: $8
Current: $1.17
Upside: +583.76%
Feb 25, 2022
Initiates: Buy
Price Target: $100
Current: $3.39
Upside: +2,846.38%
Nov 24, 2021
Initiates: Buy
Price Target: $400
Current: $1.25
Upside: +31,900.00%
Sep 27, 2021
Upgrades: Buy
Price Target: $600 → $1,920
Current: $0.19
Upside: +1,031,603.39%
May 28, 2021
Maintains: Buy
Price Target: $2,816 → $2,200
Current: $0.33
Upside: +666,566.67%
Mar 11, 2021
Initiates: Buy
Price Target: $38
Current: $6.30
Upside: +503.17%
Feb 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.33
Upside: +35,990.23%
Nov 17, 2020
Downgrades: Sell
Price Target: $96
Current: $6.82
Upside: +1,307.62%
Dec 19, 2019
Initiates: Buy
Price Target: n/a
Current: $5.39
Upside: -